No profile data available.
Aarey Drugs & Pharmaceuticals Limited (AAREYDRUGS.NS) is a healthcare company in the drug manufacturing contractors industry, based in Mumbai, India.
It reported revenue of 4.72 billion INR for fiscal year 2025, up 19.5% from fiscal year 2024, and net income of 40.24 million INR. In Q3 2026 (the quarter ended December 31, 2025) revenue was 964.26 million INR, down 27.9% from a year before. Its market capitalization was 3.32 billion INR as of October 9, 2026.
Figures from company filings and market data; latest fiscal year ended March 31, 2025; market data as of October 9, 2026.
Aarey Drugs & Pharmaceuticals Limited manufactures and sells active pharmaceutical ingredients, intermediates, and specialty chemicals for various industrial applications in India. The company offers intermediates, including mono methyl urea, di methyl urea, ortho para nitro anisole, 2-bromomethyl-1,3-dioxolane, and uracil.
Aarey Drugs & Pharmaceuticals reported 4.72 billion INR in revenue for fiscal year 2025, up 19.5% from 3.95 billion INR in fiscal year 2024. In Q3 2026 revenue was 964.26 million INR.
3.32 billion INR as of October 9, 2026.
Listed companies of a similar size in the same industry (drug manufacturing contractors) include Wanbury Limited (WANBURY.NS), Haleos Labs Limited (SMSLIFE.BO), Medicamen Biotech Limited (MEDICAMEQ.NS), BDH Industries Limited (BDH.BO).